New Products, Programs in Smoking Cessation Sector Offer Hope, Support to Those Desperate to Quit
FN Media Group Presents NetworkNewsWire Market Commentary New York, NY – October 1, 2020 – Smoking is the leading cause of preventable death in the world today. Globally, 7 million people die every year from tobacco use, and the number is projected to increase to 8 million if the pattern of smoking doesn’t change. […]
Elevated Silver Prices Shine Light on Bonanza-Grade Silver Discoveries in Mexico
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – October 1, 2020 – Silver has been consistently outperforming gold this year, creating some serious excitement around the silver market and the companies operating in prolific regions. Although silver has come down from its high of $29.85, it’s still up over 75% since […]
Growing Adoption of CBD Pharmaceutical Grade and Wellness Products Having Healthy Impact on Market Growth
Palm Beach, FL – October 1, 2020 – The global CBD and CBD oil market revenues are projected to continue to rise significantly in the coming years. Increasing consumer preference for various cannabidiol infused products such as capsules, cannabis oil, beverages, beauty and skincare products, gummies, and dog treats is further anticipated to drive the […]
Global Brain Tumor Therapeutics Market Projected to Exceed $2.70 Billion By 2023
Palm Beach, FL – October 1, 2020 – The global market for brain tumor therapeutics is projected to see significant growth over the next several years. A brain tumor is an abnormal growth of tissue in the brain or central spine that can disrupt proper brain function. Although there are standard treatments such as surgery […]
Moleculin Announces Positive Interim Results in Pediatric Brain Tumor Phase 1 Clinical Trial at Emory University
WP1066 demonstrates activity in DIPG, rare form of pediatric brain tumor Houston, TX – October 1, 2020 — Moleculin Biotech, Inc., (NASDAQ: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting significant unmet needs in the treatment of tumors and viruses, announced preliminary first cohort […]
